Korsana Biosciences, Inc. (NASDAQ: KRSA) is a Healthcare company (Biotechnology) with a market capitalization of $152M. The Maz Rating grades it against the other companies in its sector.
Korsana Biosciences, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $32.50, Korsana Biosciences, Inc. trades at 149.3x sales and 0.0x book value, with an EV/EBITDA of 5.6. Over the last twelve months it generated about $1M of revenue and a net loss of $1.6B. It runs a gross margin of 25.6%, an operating margin of -5277.3% and a net margin of -5088.4%. It shows return on equity of -50.6%, return on invested capital of -12.9% and a free cash flow yield of -33.5%. On the balance sheet: a debt-to-equity ratio of 0.00 and a current ratio of 10.42. Over the past 52 weeks the share price ranged from $7.19 to $59.36, with a beta of 1.84.
Korsana Biosciences, Inc. does not currently pay a dividend.
2 Wall Street analyst ratings cover the stock: 2 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.